SCHEMBL23747846

SCHEMBL23747846

C=C(C)CCN(CCC)C(CC)CC

nearest known ligand 0.33

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
FDPS P14324 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19334565 0.79 FDPS (0.40) FDPS
SCHEMBL3106202 0.70 FDPS (0.39) FDPS
SCHEMBL13522719 0.70 CA12 (0.37)
SCHEMBL20133761 0.70
SCHEMBL24267559 0.69 FDPS (0.32) FDPS
SCHEMBL22422351 0.69 FDPS (0.37) FDPS
Hydrochloric Acid SCHEMBL22771754 0.69 CA12 (0.36)
SCHEMBL27305990 0.69 FDPS (0.33) FDPS
SCHEMBL20468809 0.68
SCHEMBL19112826 0.67 FDPS (0.36) FDPS

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021155426-A1 QUINAZOLINE COMPOUNDS AND THE USE THEREOF IN THE TREATMENT OF CANCER TroBio Therapeutics Pty Ltd (AU) 2021-08-12 WO disclosed